Tuesday, November 17, 2026Latest
Michigan News

Michigan child’s rare disease inspires $7.6 million NIH research grant

Corewell Health and Michigan State University have received a $7.6 million grant from the National Institutes of Health to expand rare disease research and clinical care. The funding supports the Center for Polyamine Disorders, which was founded in 2017 to translate laboratory discoveries into patient treatment.

The grant builds on the story of Marley Berthoud, a Grand Rapids child whose diagnosis helped identify Bachmann-Bupp Syndrome. Her treatment with the drug DFMO, developed through a partnership between MSU scientists and Corewell physicians, reversed her symptoms and established a model for bridging lab research with bedside care.

Led by Dr. Caleb Bupp and Dr. André Bachmann, the project will partner with Johns Hopkins University and the Snyder-Robinson Foundation. The initiative is part of the NIH Rare Diseases Clinical Research Network and aims to help families with Bachmann-Bupp Syndrome and related polyamine disorders.

Read the full story at newsroom.corewellhealth.org.

Leave a Reply